Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
SAN FRANCISCO, Oct. 26, 2016 -- Hagens Berman Sobol Shapiro LLP reminds investors in National Beverage Corp. (NASDAQ:FIZZ) of the December 5, 2016 Lead Plaintiff deadline in the securities fraud lawsuit filed in the U.S. District Court for the Central District of California.
If you purchased or otherwise acquired securities of FIZZ between July 16, 2015 and September 28, 2016 and suffered over $50,000 in losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/FIZZ
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On September 28, 2016, the price of FIZZ shares fell by over 8% on unusually heavy volume in response to a Glaucus Research Group report detailing its conclusion that FIZZ manipulated its earnings for years.
According to the Glaucus report, a former attorney and trusted advisor of FIZZ CEO Nick Caporella testified under oath that Caporella “admitted…that he manipulated earnings using a ‘little jewel box’ and by creating fake invoices.” There were many other disturbing items Glaucus included within its report. If true, they implicate potential accounting fraud and securities law violations.
“We’re evaluating the cited documents in the context of FIZZ’s historical financial results that it reported to investors,” said Hagens Berman partner Reed Kathrein. “Smoothing earnings and generating fake invoices are obviously violations of generally applicable accounting principles and the securities laws.”
Whistleblowers: Persons with non-public information regarding National Beverage Corp. should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
